Prospective evaluation of angiogenic, hypoxic and EGFR-related biomarkers in recurrent glioblastoma multiforme treated with cetuximab, bevacizumab and irinotecan

✍ Scribed by Benedikte Hasselbalch; Jesper Grau Eriksen; Helle Broholm; Ib Jarle Christensen; Kirsten Grunnet; Michael R. Horsman; Hans Skovgaard Poulsen; Marie-Thérése Stockhausen; Ulrik Lassen

• Book ID: 109344068
• Publisher: John Wiley and Sons
• Year: 2010
• Tongue: English
• Weight: 513 KB
• Volume: 118
• Category: Article
• ISSN: 0365-5555
• DOI: 10.1111/j.1600-0463.2010.02631.x